Search results
Careers | Merck. Get tailored job recommendations based on your interests and find your next career opportunity with us. DISCOVER MORE ABOUT US. Work Areas. Are you looking for a challenge that’s both rewarding and fulfilling? Start your career at Merck and join a global team with a passion to pioneer. Explore More. Students & Graduates.
2 dni temu · However, Merck’s (NYSE:MRK) non-GAAP earnings per share stood in line with consensus falling ~26% YoY to $1.57, including a $0.79 per share impact from certain business development activities.
1 dzień temu · The company’s stock has experienced a notable decline, over 20% since 2Q24, primarily due to this issue, yet Seigerman believes this drop does not truly reflect Merck’s business fundamentals.
2 dni temu · Merck & Co posted higher-than-expected third-quarter earnings on Thursday on strong sales of its blockbuster cancer treatment Keytruda, but the U.S. drugmaker also flagged a second straight ...
2 dni temu · Here’s what Merck reported for the third quarter compared with what Wall Street was expecting, based on a survey of analysts by LSEG: Earnings per share: $1.57 adjusted vs. $1.50 expected ...
Merck & Co. Inc.’s stock fell 3% Thursday, after the drug company beat profit and sales estimates for the third quarter, but lowered guidance due to charges stemming from deals with partners ...
25 paź 2024 · MRK. Merck MRK will report its third-quarter earnings on Oct. 31, before market open. The Zacks Consensus Estimate for sales and earnings is pegged at $16.54 billion and $1.54 per share ...